2020 Veeva Europe R&D Summit: Speeding Trials with Unified Clinical Operations

Modernizing clinical trial systems and processes to accelerate clinical research were key themes for the more than 390 clinical operations professionals that gathered at the first virtual Veeva Europe R&D Summit in mid-May. This year's clinical operations track featured four engaging customer sessions in which AstraZeneca, GSK, Cancer Research UK (CRUK), and Quality, Regulatory, and Clinical Consultancy (QRC) shared inspiring ideas, strategies, and results.

Anders Persson, digital transformation leader at AstraZeneca, kicked off the clinical operations track by discussing how the company is redefining clinical trial execution by streamlining and changing a paper-based process that has remained the same for decades. The company launched a multi-phase deployment and change management program 18 months ago to transform operations for 7,000 users across more than 40 countries. Learn more about AstraZeneca's vision, its comprehensive multi-year process, the benefits already achieved, and how their unified solution is transforming study design and execution. Watch this information-packed session here.

The importance of modernizing clinical trial systems and processes to speed trials was echoed by Stephen Nabarro, head of clinical operations and data management at CRUK. The company is using Vault eTMF and says Nabarro, 'there is absolute evidence that it's accelerating our clinical trials.' Among the many achievements: financial payback earlier than predicted, major gains from leveraging document workflow and reporting functionality, and some unexpected but welcome benefits from remote use of the solution during the COVID-19 pandemic. For full details, including quantified metrics on realized benefits, view the CRUK presentation.

QRC leveraged best practices to transition away from paper TMFs, while keeping their business goals and clinical trials on track. Alex Gage, head of clinical operations, discussed the company's move to a modern, purpose-built eTMF system. In just six weeks, QRC progressed from project planning to implementation, training, and go live. They initiated their first eTMF project five days later, and now have eight studies live with over 3,000 documents approved. For more on what QRC achieved - and to hear their seven key recommendations for implementation and rollout - watch the QRCC session.

Summit attendees heard about the benefits of active TMF management from Simon Trowell, vice president for quality and risk management at GSK. His presentation focused on the company's search for a new way to manage TMFs. The key drivers for change were compliance and quality, along with a desire to simplify and consolidate multiple TMF systems around a single platform and one way of working. For more on the benefits GSK has realized with Vault eTMF, and the clear synergies they see with other Veeva applications, view the GSK presentation.

To view these sessions on-demand through June 17, please register here.